Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-25
2005-10-25
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S321000, C514S326000, C546S209000, C546S208000, C546S207000, C546S210000, C546S211000, C546S194000
Reexamination Certificate
active
06958350
ABSTRACT:
The invention provides a compound of formula (I): wherein R1, R2, R3, R4, R5, N, X and Y are as defined in the specification, processes, for their preparation, pharmaceutical compositions containing them, and their use in therapy, especially for the treatment of chemokine receptor related diseases and conditions.
REFERENCES:
patent: 3203992 (1965-08-01), Kunz et al.
patent: 3577432 (1971-05-01), Helsley et al.
patent: 3755584 (1973-08-01), Plotnikoff et al.
patent: 3818017 (1974-06-01), Janssen et al.
patent: 3894030 (1975-07-01), Janssen et al.
patent: 4029801 (1977-06-01), Cavalla et al.
patent: 4105666 (1978-08-01), Ward
patent: 4105771 (1978-08-01), Archibald et al.
patent: 4166119 (1979-08-01), Effland et al.
patent: 4246267 (1981-01-01), Vincent et al.
patent: 4264613 (1981-04-01), Regnier et al.
patent: 4338323 (1982-07-01), Regnier et al.
patent: 5576321 (1996-11-01), Krushinski, Jr. et al.
patent: 5614523 (1997-03-01), Audia et al.
patent: 5614533 (1997-03-01), Anderson et al.
patent: 5627196 (1997-05-01), Audia et al.
patent: 5688960 (1997-11-01), Shankar
patent: 5696267 (1997-12-01), Reichard et al.
patent: 5741789 (1998-04-01), Hibschman et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5840725 (1998-11-01), Reichard et al.
patent: 37 23 568 (1989-01-01), None
patent: 197 03 131 (1998-07-01), None
patent: 197 55 268 (1999-06-01), None
patent: 0 095 454 (1983-11-01), None
patent: 0 128 007 (1984-12-01), None
patent: 0 354 568 (1990-02-01), None
patent: 0 407 217 (1991-01-01), None
patent: 0 445 862 (1991-09-01), None
patent: 0 457 686 (1991-11-01), None
patent: 0 496 691 (1992-07-01), None
patent: 0 587 311 (1994-03-01), None
patent: 0 625 507 (1994-11-01), None
patent: 0 643 057 (1995-03-01), None
patent: 0 722 941 (1996-07-01), None
patent: 0 903 349 (1999-03-01), None
patent: 1 013 276 (2000-06-01), None
patent: 2 190 430 (1974-02-01), None
patent: 1368012 (1974-09-01), None
patent: 1 404 868 (1975-09-01), None
patent: 1 425 354 (1976-02-01), None
patent: 1 532 671 (1978-11-01), None
patent: 1 538 542 (1979-01-01), None
patent: 1 544 191 (1979-04-01), None
patent: 63-264525 (1988-11-01), None
patent: 10259176 (1998-09-01), None
patent: WO 92/15579 (1992-09-01), None
patent: WO 93/13083 (1993-07-01), None
patent: WO 93/25528 (1993-12-01), None
patent: WO 94/27967 (1994-12-01), None
patent: WO 95/11880 (1995-05-01), None
patent: WO 96/26205 (1996-08-01), None
patent: WO 96/34857 (1996-11-01), None
patent: WO 96/39386 (1996-12-01), None
patent: WO 97/10207 (1997-03-01), None
patent: WO 97/19060 (1997-05-01), None
patent: WO 97/23458 (1997-07-01), None
patent: WO 97/42956 (1997-11-01), None
patent: WO 97/47299 (1997-12-01), None
patent: WO 98/02151 (1998-01-01), None
patent: WO 98/08826 (1998-03-01), None
patent: WO 98/31364 (1998-07-01), None
patent: WO 98/31366 (1998-07-01), None
patent: WO 98/32442 (1998-07-01), None
patent: WO 98/51311 (1998-11-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 99/27928 (1999-06-01), None
patent: WO 99/27929 (1999-06-01), None
patent: WO 99/28314 (1999-06-01), None
patent: WO 99/31092 (1999-06-01), None
patent: WO 99/37304 (1999-07-01), None
patent: WO 99/37619 (1999-07-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 99/64394 (1999-12-01), None
patent: WO 99/65895 (1999-12-01), None
patent: WO 00/08013 (2000-02-01), None
patent: WO 00/21948 (2000-04-01), None
patent: WO 00/21952 (2000-04-01), None
patent: WO 00/23076 (2000-04-01), None
patent: WO 00/35449 (2000-06-01), None
patent: WO 00/35451 (2000-06-01), None
patent: WO 00/39108 (2000-07-01), None
patent: WO 00/53600 (2000-09-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO 00/61559 (2000-10-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 00/76513 (2000-12-01), None
patent: WO 00/76973 (2000-12-01), None
patent: WO 01/14333 (2001-03-01), None
patent: WO 01/43744 (2001-06-01), None
patent: WO 01/44227 (2001-06-01), None
patent: WO 01/87839 (2001-11-01), None
patent: WO 01/92227 (2001-12-01), None
patent: WO 02/070479 (2002-09-01), None
patent: WO 02/076948 (2002-10-01), None
patent: WO 02/079156 (2002-10-01), None
patent: WO 02/079256 (2002-10-01), None
patent: WO 03/042177 (2003-05-01), None
patent: WO 03/042178 (2003-05-01), None
patent: WO 03/042205 (2003-05-01), None
Rollins BJ. Blood. 1997, 90(3): 909-928.
U.S. Appl. No. 10/204,754, filed Aug. 23 2002, Hansen et al.
U.S. Appl. No. 10/204,789, filed Aug. 23, 2002, Hansen et al.
U.S. Appl. No. 10/204,790, filed Aug. 23, 2002, Bodkin et al.
U.S. Appl. No. 10/311,667, filed Dec. 17, 2002, Eriksson et al.
U.S. Appl. No. 10/311,841, filed Dec. 17, 2002, Eriksson et al.
U.S. Appl. No. 10/472,017, filed Sep. 19, 2003, Eriksson et al.
U.S. Appl. No. 10/472,412, filed Sep. 16, 2003, Eriksson et al.
Archibald et al., “Antiinflammatory 4-acylaminopiperidines”,CAPLUS77:34355 (1972).
Cattanach et al., “Studies in the Indole Series. Part IV. Tetrahydro-1H-pyrido[4, 3-b]-indoles as Serotonin Antagonists”,J. Chem. Soc. C.10:1235-1243 (1968).
Cohen et al., “Cytokine function: A study in biologic diversity”,CAPLUS125:31527 (1996).
Friebe et al., “Piperidinopropyl derivatives and pharmaceutical compositions containing them”,CAPLUS94:103172 (1981).
Hesselgesser et al., “Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor”,J. Biol. Chem.273(25):15687-15692 (1998).
Howard et al., “Chemokines: progress toward identifying molecular targets for therapeutic agents”,Trends in Biotechnology14:46-51 (1996).
Manabu Hori Kim D. Janda, “A Soluble Polymer Approach to the “Fishing Out” Principle: Synthesis and Purification of β-Amino Alcohols”,J. Org. Chem.63:889-894 (1998).
Komai et al., “Structure-Activity Relationships of HIV-1 PR Inhibitors Containing AHPBA-II. Modification of Pyrrolidine Ring at P1' Proline”,Bioorganic&Medicinal Chemistry4(8):1365-1377 (1996).
Leclerc et al., “Derivatives Related to Betaxolol with I-and J-Adrenergic Activities”,Arzneim.-Forsch/Drug. Res.35(11):1357-1367 (1985).
Meurer et al., “Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection—II.”,CAPLUS2000:331722 (2000).
Navas III et al., “The Design and Synthesis of a Hapten for 1192U90, A Potential Atypical Antipsychotic Agent”,Synthetic Communications26(7):1411-1421 (1996).
Payard et al., “N-Aminomethylated Derivatives of Some Hydroxamine Acids as Anti-Inflammatories”,Eur. J. Med. Chem.pp. 1-10 (1975).
Rubini et al., “Synthesis of Isosteric Methylene-Oxy Pseudodipeptide Analogues as Novel Amide Bond Surrogate Units”,Tetrahedron42(21):6039-6045 (1986).
STN Int'l,CAPLUS1968.402884.
Timmermans et al., “Hypotensive Properties of Benzodioxane Derivatives Structurally Related to R 28935. Comparison of Activity with some Receptor Affinities”,Arch. int. Pharmacodyn.255:321-334 (1982).
Wright et al., “Discovery of Selective Dopamine D4 Receptor Antagonists: 1-Aryloxy-3-(4-Aryloxypiperidinyl)-2-Propanols”,Bioorganic&Medicinal Chemistry Letters7(11):1377-1380 (1997).
Archibald et al., “Antiinflammatory 4-acylaminopiperidines”,CAPLUS77:34355 (1972).
CAPLUS accession No. 1978:22640, document No. 88:22640, Yoshitomi Pharmaceutical Industries Ltd.: “Urea and thiourea derivatives” & JP, A2, 52085174, 19770715.
CAPLUS, accession No. 1990:558675, document No. 113:158675, Yoshitomi Pharmaceutical Industries, Ltd.: “Dihydroxycinnamic acid amide derivatives and their pharmaceutical compositions for enhancement of nerve growth factor (NGF) production” & JP, A2, 02104568, 19900417.
Derwent Abstract 54050W/33 corresponding to Belgium Application BE 826994.
Derwent Abstract 2000-339628/29 corresponding to PCT Application WO 00/23437 A1.
Derwent Abstract 96-136185/14 corresponding to Japanese Patent Application JP 08026999.
Derwent Abstra
Brough Stephen
McInally Thomas
Perry Matthew
Springthorpe Brian
AstraZeneca AB
Fish & Richardson P.C.
Huang Evelyn Mei
LandOfFree
Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3491818